Evidence map›Paper›PMID 35396497›Full record

ArticleScientific reports2022

Retraction Note: HMGB1 Facilitated Macrophage Reprogramming towards a Proinflammatory M1-like Phenotype in Experimental Autoimmune Myocarditis Development.

Zhaoliang Su, Pan Zhang, Ying Yu, Hongxiang Lu, Yanfang Liu, Ping Ni, Xiaolian Su, Dan Wang, Yueqin Liu, Jia Wang and 3 more

RetractedOpen access · goldAbstract readRetraction Notice
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Zhaoliang SuDepartment of Immunology, Jiangsu University, Zhenjiang, 212013, China.
Pan ZhangDepartment of Immunology, Jiangsu University, Zhenjiang, 212013, China.
Ying YuDepartment of Immunology, Jiangsu University, Zhenjiang, 212013, China.
Hongxiang LuDepartment of Immunology, Jiangsu University, Zhenjiang, 212013, China.
Yanfang LiuDepartment of Immunology, Jiangsu University, Zhenjiang, 212013, China.
Ping NiDepartment of Immunology, Jiangsu University, Zhenjiang, 212013, China.
Xiaolian SuDepartment of Immunology, Jiangsu University, Zhenjiang, 212013, China.
Dan WangDepartment of Immunology, Jiangsu University, Zhenjiang, 212013, China.
Yueqin LiuThe Central Laboratory, the Fourth Affiliated Hospital of Jiangsu University, Zhenjiang, 212001, China.
Jia WangDepartment of Immunology, Jiangsu University, Zhenjiang, 212013, China.
Huiling ShenThe Central Laboratory, the Fourth Affiliated Hospital of Jiangsu University, Zhenjiang, 212001, China.
Wenlin XuThe Central Laboratory, the Fourth Affiliated Hospital of Jiangsu University, Zhenjiang, 212001, China.
Huaxi XuDepartment of Immunology, Jiangsu University, Zhenjiang, 212013, China. szl30@yeah.net.
Jiangsu University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35396497
PMCPMC8993794
OpenAlexW4223615733

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.